Rejected at 8:51 p.m. May, 30, 2024 ] by Cameron
Author: christianphoward
Related Note: 1578183592464
Rationale for change

I think the card should be more specify they are taken as preventive measures per the additional info section

Rejection reason

Card structure makes this evident

Text Text
Extra
Reduce effects of estrogen at the breast

Selective Estrogen Receptor Modulators (SERMs)BreastUterusBone
Tamoxifen-++
Raloxifene--+
Clomiphene- (in hypothalamus)
ER agonist = +; ER antagonist = -
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy

Watch SERMs & Aromatase Inhibitors
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Pharmacology: Selective Estrogen Receptor Modulators

Watch associated Bootcamp video - Cellular Injury and Neoplasia: Cell Cycle Independent Drug Targets

Watch associated Bootcamp video - Principles of Oncology and Therapeutics: Cell Cycle Independent Drug Targets
OME

Additional Resources
One by one
Empty field
AnkiHub_ImageReady::Text #AK_Step2_v12::#OME_banner #AK_Step2_v12::#Subjects::Obstetrics_&_Gynecology::01_Gynecology::Breast::Breast_Cancer !AK_UpdateTags::Table::SERMs #AK_Step2_v12::!Shelf::#Cards_AnKing_Did::4fm #AK_Step1_v12::#B&B::11_Hematology::04_Cancer_Drugs::06_Other_Cancer_Drugs::Extra #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step2_v12::!Shelf::FM::no_dupes::only_step2 #AK_Step2_v12::Original_decks::Dorian::fam::uspstf_guidelines #AK_Step1_v12::#Bootcamp::Reproduction::06_Pharmacology::02_Selective_Estrogen_Receptor_Modulators #AK_Step2_v12::!Shelf::FM::no_dupes !AK_UpdateTags::Step2decks::Cheesy-Dorian-(M3)::Family-Medicine::2-USPSTF-Guidelines #AK_Step1_v12::#AMBOSS::j4a_Qk AnkiHub_ImageReady::Extra #AK_Step2_v12::#Subjects::Obstetrics_&_Gynecology::01_Gynecology::Breast::Breast_Cancer::Management !AK_UpdateTags::^temporary::ImageFix::22::done #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::05_Sex_Hormones::01_SERMs_&_Aromatase_Inhibitors #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::11_Cell_Cycle_Independent_Drug_Targets #AK_Step2_v12::#Resources_by_rotation::FM::uspstf_guidelines